Published in Crit Care on March 20, 2002
Measuring paternal discrepancy and its public health consequences. J Epidemiol Community Health (2005) 2.30
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
The sequence of the human genome. Science (2001) 101.55
Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science (1995) 68.34
A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature (2001) 42.18
Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature (2001) 16.89
Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18. Nature (2001) 15.44
Genome sequence of Yersinia pestis, the causative agent of plague. Nature (2001) 14.36
Variations on a theme: cataloging human DNA sequence variation. Science (1997) 10.49
Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA (1999) 3.51
Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group. Crit Care Med (1993) 2.84
Parallel genotyping of human SNPs using generic high-density oligonucleotide tag arrays. Genome Res (2000) 2.79
Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review. JAMA (2001) 2.49
The use of single-nucleotide polymorphism maps in pharmacogenomics. Nat Biotechnol (2000) 2.04
High-throughput multiplex SNP genotyping with MALDI-TOF mass spectrometry: practice, problems and promise. Hum Mutat (2001) 1.80
SBE-TAGS: an array-based method for efficient single-nucleotide polymorphism genotyping. Proc Natl Acad Sci U S A (2000) 1.74
Implications of the human genome for understanding human biology and medicine. JAMA (2001) 1.47
Clinical trials of mediator-directed therapy in sepsis: what have we learned? Intensive Care Med (2000) 1.11
Whole-genome analysis: annotations and updates. Curr Opin Struct Biol (2001) 1.08
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med (2007) 13.90
High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med (2015) 10.15
High versus low blood-pressure target in patients with septic shock. N Engl J Med (2014) 7.37
Intravascular Complications of Central Venous Catheterization by Insertion Site. N Engl J Med (2015) 7.02
Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial. JAMA (2013) 3.78
Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. JAMA (2010) 3.50
Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). Crit Care Med (2009) 3.07
Induced hypothermia in severe bacterial meningitis: a randomized clinical trial. JAMA (2013) 2.97
The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy. Immunol Rev (2007) 2.96
Immediate percutaneous coronary intervention is associated with better survival after out-of-hospital cardiac arrest: insights from the PROCAT (Parisian Region Out of hospital Cardiac ArresT) registry. Circ Cardiovasc Interv (2010) 2.91
Prognostication in comatose survivors of cardiac arrest: an advisory statement from the European Resuscitation Council and the European Society of Intensive Care Medicine. Resuscitation (2014) 2.76
Short- and long-term outcome in elderly patients after out-of-hospital cardiac arrest: a cohort study. Crit Care Med (2014) 2.70
Influence of overweight on ICU mortality: a prospective study. Chest (2004) 2.54
Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center. Crit Care Med (2012) 2.51
Predicting survival with good neurological recovery at hospital admission after successful resuscitation of out-of-hospital cardiac arrest: the OHCA score. Eur Heart J (2006) 2.30
Reversible myocardial dysfunction in survivors of out-of-hospital cardiac arrest. J Am Coll Cardiol (2002) 2.27
Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]. Crit Care (2004) 2.25
Important questions asked by family members of intensive care unit patients. Crit Care Med (2011) 2.22
Characteristics and prognosis of sudden cardiac death in Greater Paris: population-based approach from the Paris Sudden Death Expertise Center (Paris-SDEC). Intensive Care Med (2014) 2.16
Benefit of an early and systematic imaging procedure after cardiac arrest: insights from the PROCAT (Parisian Region Out of Hospital Cardiac Arrest) registry. Resuscitation (2012) 2.13
Brain natriuretic peptide: A marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med (2004) 2.05
Specific MAIT cell behaviour among innate-like T lymphocytes in critically ill patients with severe infections. Intensive Care Med (2013) 2.02
Association between a genomic polymorphism within the CD14 locus and septic shock susceptibility and mortality rate. Crit Care Med (2002) 1.97
Postresuscitation disease after cardiac arrest: a sepsis-like syndrome? Curr Opin Crit Care (2004) 1.93
Temporal changes in management and outcome of septic shock in patients with malignancies in the intensive care unit. Crit Care Med (2008) 1.89
Severe imported falciparum malaria: a cohort study in 400 critically ill adults. PLoS One (2010) 1.86
Soluble thrombomodulin, plasma-derived unactivated protein C, and recombinant human activated protein C in sepsis. Crit Care Med (2002) 1.81
Recombinant human activated protein C for adults with septic shock: a randomized controlled trial. Am J Respir Crit Care Med (2013) 1.81
Prognostic value of relative adrenal insufficiency after out-of-hospital cardiac arrest. Intensive Care Med (2005) 1.71
Infectious complications in out-of-hospital cardiac arrest patients in the therapeutic hypothermia era. Crit Care Med (2011) 1.68
IRAK1 functional genetic variant affects severity of septic shock. Crit Care Med (2010) 1.64
Is hypothermia after cardiac arrest effective in both shockable and nonshockable patients?: insights from a large registry. Circulation (2011) 1.63
Out-of-hospital cardiac arrest from brain cause: epidemiology, clinical features, and outcome in a multicenter cohort*. Crit Care Med (2015) 1.62
Long-term prognosis following resuscitation from out of hospital cardiac arrest: role of percutaneous coronary intervention and therapeutic hypothermia. J Am Coll Cardiol (2012) 1.62
Early-onset pneumonia after cardiac arrest: characteristics, risk factors and influence on prognosis. Am J Respir Crit Care Med (2011) 1.62
Biological evaluation of perioperative cardiac stress: a two-way approach. Crit Care Med (2006) 1.60
Brainstem responses can predict death and delirium in sedated patients in intensive care unit. Crit Care Med (2011) 1.59
Impact of case volume on survival of septic shock in patients with malignancies. Crit Care Med (2012) 1.58
Coronavirus 229E-related pneumonia in immunocompromised patients. Clin Infect Dis (2003) 1.58
The importance of Toll-like receptor 2 polymorphisms in severe infections. Clin Infect Dis (2005) 1.57
Plasma-induced endothelial oxidative stress is related to the severity of septic shock. Crit Care Med (2007) 1.57
High-volume hemofiltration after out-of-hospital cardiac arrest: a randomized study. J Am Coll Cardiol (2005) 1.56
Outcome of severe adult thrombotic microangiopathies in the intensive care unit. Intensive Care Med (2004) 1.56
Blood glucose level and outcome after cardiac arrest: insights from a large registry in the hypothermia era. Intensive Care Med (2014) 1.51
Experts' recommendations for the management of adult patients with cardiogenic shock. Ann Intensive Care (2015) 1.51
Ability of family members to predict patient's consent to critical care research. Intensive Care Med (2007) 1.50
Postresuscitation syndrome: potential role of hydroxyl radical-induced endothelial cell damage. Crit Care Med (2011) 1.47
Comparison between Flotrac-Vigileo and Bioreactance, a totally noninvasive method for cardiac output monitoring. Crit Care (2009) 1.46
Prognostication in comatose survivors of cardiac arrest: an advisory statement from the European Resuscitation Council and the European Society of Intensive Care Medicine. Intensive Care Med (2014) 1.43
Coagulopathy after successful cardiopulmonary resuscitation following cardiac arrest: implication of the protein C anticoagulant pathway. J Am Coll Cardiol (2005) 1.43
Changes in cerebral blood flow and oxygen extraction during post-resuscitation syndrome. Resuscitation (2007) 1.42
High Level of Endotoxemia Following Out-of-Hospital Cardiac Arrest Is Associated With Severity and Duration of Postcardiac Arrest Shock. Crit Care Med (2015) 1.41
Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports. J Clin Oncol (2005) 1.40
Disulfiram ethanol reaction mimicking anaphylactic, cardiogenic, and septic shock. Am J Emerg Med (2012) 1.39
Is copeptin level associated with 1-year mortality after out-of-hospital cardiac arrest? Insights from the Paris registry*. Crit Care Med (2015) 1.38
Major regional disparities in outcomes after sudden cardiac arrest during sports. Eur Heart J (2013) 1.35
Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience. PLoS One (2010) 1.33
Improving clinical trials in the critically ill. Crit Care Med (2010) 1.33
Intensive care unit mortality after cardiac arrest: the relative contribution of shock and brain injury in a large cohort. Intensive Care Med (2013) 1.27
Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement. Medicine (Baltimore) (2004) 1.21
Specific antioxidant properties of human serum albumin. Ann Intensive Care (2013) 1.19
Toward theragnostics. Crit Care Med (2009) 1.15
Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience. Haematologica (2012) 1.13
Epidemiology and outcome of severe pneumococcal pneumonia admitted to intensive care unit: a multicenter study. Crit Care (2012) 1.09
Timing and causes of death in septic shock. Ann Intensive Care (2015) 1.09
Unusual "flesh-eating" strain of Escherichia coli. J Clin Microbiol (2010) 1.03
Importance of hemostatic gene polymorphisms for susceptibility to and outcome of severe sepsis. Crit Care Med (2004) 1.02
Bench-to-bedside review: severe lactic acidosis in HIV patients treated with nucleoside analogue reverse transcriptase inhibitors. Crit Care (2003) 1.01
Dendritic cells modulate lung response to Pseudomonas aeruginosa in a murine model of sepsis-induced immune dysfunction. J Immunol (2008) 1.00
The PIRO concept: P is for predisposition. Crit Care (2003) 1.00
High levels of catalytic antibodies correlate with favorable outcome in sepsis. Proc Natl Acad Sci U S A (2005) 0.99
Failure of deferasirox, an iron chelator agent, combined with antifungals in a case of severe zygomycosis. Antimicrob Agents Chemother (2008) 0.98
European Resuscitation Council and European Society of Intensive Care Medicine 2015 guidelines for post-resuscitation care. Intensive Care Med (2015) 0.97
Postcardiac arrest syndrome: from immediate resuscitation to long-term outcome. Ann Intensive Care (2011) 0.96
Health-related quality of life in family members of intensive care unit patients. J Palliat Med (2010) 0.96
Peripheral blood neutrophil activation patterns are associated with pulmonary inflammatory responses to lipopolysaccharide in humans. J Immunol (2006) 0.95